Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-017875
Filing Date
2025-07-03
Accepted
2025-07-03 17:27:03
Documents
91

Document Format Files

Seq Description Document Type Size
1 S-1 forms-1.htm   iXBRL S-1 5143253
2 EX-5.1 ex5-1.htm EX-5.1 11451
3 EX-21.1 ex21-1.htm EX-21.1 6529
4 EX-23.1 ex23-1.htm EX-23.1 5235
5 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 22906
6 GRAPHIC formdrs_001.jpg GRAPHIC 23623
7 GRAPHIC formdrs_002.jpg GRAPHIC 37690
8 GRAPHIC ex5-1_001.jpg GRAPHIC 8239
  Complete submission text file 0001641172-25-017875.txt   18497473

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE cldi-20250331.xsd EX-101.SCH 105553
10 XBRL CALCULATION FILE cldi-20250331_cal.xml EX-101.CAL 105242
11 XBRL DEFINITION FILE cldi-20250331_def.xml EX-101.DEF 469175
12 XBRL LABEL FILE cldi-20250331_lab.xml EX-101.LAB 822259
13 XBRL PRESENTATION FILE cldi-20250331_pre.xml EX-101.PRE 597098
95 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 3273170
97 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 7004
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-288529 | Film No.: 251106446
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)